Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO): extended follow up of an open-label, randomised, multicentre, phase 3 trial

1. Dimopoulos, M.A.
2. Terpos, E.
3. Boccadoro, M.
4. Delimpasi, S.
5. Beksac, M.
6. Katodritou, E.
7. Moreau, P.
8. Baldini, L.
9. Symeonidis, A.
10. Bila, J.
11. Oriol, A.
12. Mateos, M.-V.
13. Einsele, H.
14. Orfanidis, I.
15. Kampfenkel, T.
16. Liu, W.
17. Wang, J.
18. Kosh, M.
19. Tran, N.
20. Carson, R.
21. Sonneveld, P.